GBP1 and prostate carcinoma: Collectively, our current study supports the notion that GBP1 is a oncoprotein in prostate cancer, and high levels of GBP1 protein expression is significantly associated with aggressive features in cell line models in vitro and associated with malignant features and poor overall survival in clinical samples.